HRP20210329T1 - Uređaj koji se može implantirati s intravezikalnom tolerancijom - Google Patents

Uređaj koji se može implantirati s intravezikalnom tolerancijom Download PDF

Info

Publication number
HRP20210329T1
HRP20210329T1 HRP20210329TT HRP20210329T HRP20210329T1 HR P20210329 T1 HRP20210329 T1 HR P20210329T1 HR P20210329T T HRP20210329T T HR P20210329TT HR P20210329 T HRP20210329 T HR P20210329T HR P20210329 T1 HRP20210329 T1 HR P20210329T1
Authority
HR
Croatia
Prior art keywords
retention
dimension
drug
solid
less
Prior art date
Application number
HRP20210329TT
Other languages
English (en)
Croatian (hr)
Inventor
Michael J. Cima
Heejin Lee
Original Assignee
Taris Biomedical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taris Biomedical Llc filed Critical Taris Biomedical Llc
Publication of HRP20210329T1 publication Critical patent/HRP20210329T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/18—Materials at least partially X-ray or laser opaque
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
    • A61F2/042—Urinary bladders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/22—Materials or treatment for tissue regeneration for reconstruction of hollow organs, e.g. bladder, esophagus, urether, uterus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Physics & Mathematics (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Prostheses (AREA)
HRP20210329TT 2009-12-17 2010-12-17 Uređaj koji se može implantirati s intravezikalnom tolerancijom HRP20210329T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US28764909P 2009-12-17 2009-12-17
US32571310P 2010-04-19 2010-04-19
PCT/US2010/061161 WO2011084712A1 (en) 2009-12-17 2010-12-17 Implantable device with intravesical tolerability and methods of treatment
EP10801519.9A EP2512581B1 (en) 2009-12-17 2010-12-17 Implantable device with intravesical tolerability

Publications (1)

Publication Number Publication Date
HRP20210329T1 true HRP20210329T1 (hr) 2021-06-25

Family

ID=43769298

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20210329TT HRP20210329T1 (hr) 2009-12-17 2010-12-17 Uređaj koji se može implantirati s intravezikalnom tolerancijom
HRP20250946TT HRP20250946T1 (hr) 2009-12-17 2010-12-17 Intravezikalno podnošljiv implantabilni uređaj

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20250946TT HRP20250946T1 (hr) 2009-12-17 2010-12-17 Intravezikalno podnošljiv implantabilni uređaj

Country Status (18)

Country Link
US (4) US8679094B2 (https=)
EP (2) EP3884988B1 (https=)
JP (3) JP2013514837A (https=)
AU (1) AU2010339821B2 (https=)
CA (1) CA2784601C (https=)
CY (1) CY1124354T1 (https=)
DK (2) DK2512581T3 (https=)
ES (2) ES2867399T3 (https=)
FI (1) FI3884988T3 (https=)
HR (2) HRP20210329T1 (https=)
HU (2) HUE053888T2 (https=)
LT (2) LT3884988T (https=)
PL (2) PL3884988T3 (https=)
PT (2) PT2512581T (https=)
RS (2) RS61980B1 (https=)
SI (2) SI3884988T1 (https=)
SM (2) SMT202100236T1 (https=)
WO (1) WO2011084712A1 (https=)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7645286B2 (en) 2005-05-20 2010-01-12 Neotract, Inc. Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
US9549739B2 (en) 2005-05-20 2017-01-24 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8668705B2 (en) 2005-05-20 2014-03-11 Neotract, Inc. Latching anchor device
US10925587B2 (en) 2005-05-20 2021-02-23 Neotract, Inc. Anchor delivery system
US8628542B2 (en) 2005-05-20 2014-01-14 Neotract, Inc. Median lobe destruction apparatus and method
US7758594B2 (en) 2005-05-20 2010-07-20 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US8603106B2 (en) 2005-05-20 2013-12-10 Neotract, Inc. Integrated handle assembly for anchor delivery system
US10195014B2 (en) 2005-05-20 2019-02-05 Neotract, Inc. Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
PL3884988T3 (pl) * 2009-12-17 2025-09-08 Taris Biomedical Llc Urządzenie implantowalne z tolerancją wewnątrzpęcherzową
WO2016191479A1 (en) * 2015-05-26 2016-12-01 Taris Biomedical Llc Urodynamic assessment systems and methods
US20110218488A1 (en) * 2010-03-05 2011-09-08 Taris Biomedical, Inc. Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites
US20110308835A1 (en) * 2010-06-16 2011-12-22 Piekny Mark G Self-coiling apparatus
EP3795121A1 (en) 2010-08-05 2021-03-24 TARIS Biomedical LLC Ureteral stent drug delivery device
WO2012048114A1 (en) 2010-10-06 2012-04-12 Taris Biomedical, Inc. Time-selective bioresorbable or collapsible drug delivery systems and methods
US9457176B2 (en) 2010-10-06 2016-10-04 Taris Biomedical Llc Implantable drug delivery device with bladder retention feature
US8679093B2 (en) 2010-11-23 2014-03-25 Microchips, Inc. Multi-dose drug delivery device and method
JP2014503554A (ja) * 2011-01-10 2014-02-13 タリス バイオメディカル，インコーポレイテッド 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン
EP2670398B1 (en) 2011-02-04 2017-06-07 TARIS Biomedical LLC Implantable device for controlled release of low solubility drug
US10292801B2 (en) 2012-03-29 2019-05-21 Neotract, Inc. System for delivering anchors for treating incontinence
US9883906B2 (en) 2012-04-22 2018-02-06 Newuro, B.V. Bladder tissue modification for overactive bladder disorders
US10610294B2 (en) 2012-04-22 2020-04-07 Newuro, B.V. Devices and methods for transurethral bladder partitioning
CA2872092C (en) * 2012-04-30 2021-02-16 Taris Biomedical, Inc. Methods for treatment of pelvic pain and/or comorbid conditions
EP2849725B1 (en) 2012-05-19 2020-11-25 TARIS Biomedical LLC Implantable urological device with improved retrieval feature
US10130353B2 (en) 2012-06-29 2018-11-20 Neotract, Inc. Flexible system for delivering an anchor
MX367070B (es) 2012-08-31 2019-08-05 Taris Biomedical Llc Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata.
SG11201501424SA (en) 2012-08-31 2015-03-30 Taris Biomedical Llc Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin
MX379066B (es) 2012-09-18 2025-03-04 Taris Biomedical Llc Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior.
JP2016508842A (ja) 2013-03-05 2016-03-24 タリス バイオメディカル エルエルシー 装置の開口部を通じて制御された薬物放出のための薬物送達装置及び方法
EP2968120B1 (en) 2013-03-15 2026-01-14 TARIS Biomedical LLC Drug delivery devices and methods for drug delivery
KR102557326B1 (ko) 2013-03-15 2023-07-19 타리스 바이오메디컬 엘엘씨 약물-투과성 구성요소를 가지는 약물 전달 장치
KR102385603B1 (ko) 2013-08-19 2022-04-11 타리스 바이오메디컬 엘엘씨 다중 유닛 약물 전달 장치 및 방법
EP3065807A1 (en) 2013-11-05 2016-09-14 TARIS Biomedical LLC Osmotic drug delivery devices, kits, and methods
LT4124339T (lt) * 2014-03-06 2025-11-10 Vaisto įvedimo sistemos ir būdai šlapimo pūslės vėžiui gydyti gemcitabinu
EP3142740B1 (en) 2014-05-12 2020-12-02 TARIS Biomedical LLC Drug delivery devices
KR20220061253A (ko) * 2014-06-26 2022-05-12 타리스 바이오메디컬 엘엘씨 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
US20170246437A1 (en) 2014-09-12 2017-08-31 Taris Biomedical Llc pH-MODULATING DRUG DELIVERY DEVICES AND METHODS
EP3277363B1 (en) 2015-03-30 2019-06-19 TARIS Biomedical LLC Devices for local delivery of drug to upper urinary tract
GB201505527D0 (en) 2015-03-31 2015-05-13 Jmedtech Pte Ltd Composition
WO2016172704A1 (en) 2015-04-23 2016-10-27 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
US10159850B2 (en) * 2016-01-06 2018-12-25 Covidien Lp Brachytherapy clip and applicator
US11185670B2 (en) 2016-01-26 2021-11-30 Taris Biomedical Llc Multi-lumen drug delivery devices
WO2017151983A1 (en) 2016-03-02 2017-09-08 Taris Biomedical Llc Osmotic drug delivery devices and methods of making osmotic drug delivery devices
CN118453872A (zh) 2016-05-06 2024-08-09 塔里斯生物医药公司 治疗下尿路尿道上皮癌的方法
US11707611B2 (en) 2016-11-08 2023-07-25 W. L. Gore & Associates, Inc. Implantable apparatus for retention of biological moieties
AU2017371223B2 (en) 2016-12-09 2023-04-27 Zenflow, Inc. Systems, devices, and methods for the accurate deployment of an implant in the prostatic urethra
PT3432970T (pt) 2017-02-01 2021-05-26 Taris Biomedical Llc Dispositivos de administração de fármaco in vivo
BR112020000832A2 (pt) 2017-07-25 2020-07-21 Taris Biomedical Llc métodos para tratar metástase tumoral
WO2019071245A1 (en) 2017-10-06 2019-04-11 Foundry Therapeutics, Inc. IMPLANTABLE DEPOSITS FOR REGULATED RELEASE OF ANALGESICS TO TREAT POSTHOPERATIVE PAIN ASSOCIATED WITH ORTHOPEDIC SURGERY, AND RELATED DEVICES, SYSTEMS, AND METHODS
JOP20200124A1 (ar) 2017-11-08 2020-05-20 Taris Biomedical Llc طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك
AU2018389236B2 (en) 2017-12-23 2021-05-20 Teleflex Life Sciences Llc Expandable tissue engagement apparatus and method
WO2019136490A1 (en) 2018-01-08 2019-07-11 Foundry Therapeutics, Inc. Devices, systems, and methods for treating intraluminal cancer via controlled delivery of therapeutic agents
EP3793536A1 (en) 2018-05-12 2021-03-24 Foundry Therapeutics, Inc. Implantable polymer depots for the controlled release of therapeutic agents
CN112839653A (zh) 2018-08-01 2021-05-25 塔里斯生物医药公司 使用曲司氯铵治疗膀胱过度活动症的方法
US12303619B2 (en) 2018-08-28 2025-05-20 Foundry Therapeutics, Inc. Polymer implants
WO2020096827A1 (en) 2018-11-07 2020-05-14 Neotract, Inc. System for delivery of a fiducial marker
EP4415692A1 (en) 2021-10-12 2024-08-21 TARIS Biomedical LLC Erdafitinib formulations and systems for intravesical administration
EP4710986A2 (en) 2021-12-21 2026-03-18 TARIS Biomedical LLC Urinary placement catheter for intravesical devices
CN119072311A (zh) 2022-02-18 2024-12-03 塔里斯生物医药公司 用于膀胱内施用的厄达替尼制剂和渗透系统
US12426818B2 (en) 2022-06-08 2025-09-30 Bright Uro, Inc. Packaging assembly and method of preparing sensing device for insertion into a body cavity to preserve sterility
KR20250021376A (ko) 2022-06-08 2025-02-12 브라이트 유로, 아이엔씨. 비뇨기과적 감지를 위한 시스템 및 방법
CN120435255A (zh) * 2022-06-10 2025-08-05 巴尔特美国有限责任公司 用于血管治疗的植入物和系统
WO2024092159A1 (en) 2022-10-28 2024-05-02 Taris Biomedical Llc Methods of treating bladder cancer with gemcitabine
CN120731076A (zh) 2023-02-13 2025-09-30 塔里斯生物医药公司 膀胱内施用厄达替尼以用于治疗膀胱癌
JP2026506041A (ja) 2023-02-17 2026-02-20 タリス バイオメディカル エルエルシー 膀胱がんの治療における使用のための膀胱内投与のためのエルダフィチニブ
WO2024215682A1 (en) 2023-04-10 2024-10-17 Taris Biomedical Llc Gemcitabine for use in methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guerin therapy
CN117017567B (zh) * 2023-08-12 2024-04-09 上海市第一人民医院 一种植入式膀胱收缩系统、工作方法及人造膀胱
WO2025059602A1 (en) 2023-09-14 2025-03-20 Taris Biomedical Llc Methods of treating bladder cancer using intravesical administration of erdafitinib
WO2025076007A1 (en) 2023-10-02 2025-04-10 Taris Biomedical Llc Methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guérin therapy
GB202401392D0 (en) * 2024-02-02 2024-03-20 Imphatec Ltd Implant for delivery of a drug

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016251A (en) * 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US3935860A (en) * 1974-08-21 1976-02-03 Alza Corporation Intrauterine device with restrictor for maintaining device in uterine cavity
US4968507A (en) 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
US4871542A (en) * 1987-04-30 1989-10-03 Ferring Service Center, N.V. Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
US5023088A (en) 1987-06-25 1991-06-11 Alza Corporation Multi-unit delivery system
GB2206046B (en) * 1987-06-25 1991-04-03 Alza Corp Multi-unit delivery system
PT100944B (pt) * 1991-10-10 2000-02-29 Alza Corp Dispositivo para o fornecimento osmotico de farmacos com paredes de materiais hidrofobicos
EP0572932B1 (en) 1992-06-02 2000-09-13 C.R. Bard, Inc. Method and implant device for long term delivery of drugs
US5516522A (en) * 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
EP0971641A4 (en) * 1997-04-03 2003-08-13 Point Biomedical Corp SYSTEM FOR THE ADMINISTRATION OF AN INTRAVESICAL MEDICINAL PRODUCT
US6749617B1 (en) * 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
US6160084A (en) 1998-02-23 2000-12-12 Massachusetts Institute Of Technology Biodegradable shape memory polymers
US6183461B1 (en) * 1998-03-11 2001-02-06 Situs Corporation Method for delivering a medication
US6159143A (en) * 1998-06-17 2000-12-12 Scimed Life Systems, Inc. Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
US6293923B1 (en) * 1999-03-15 2001-09-25 Innoventions, Inc. Intravesicular balloon
US7135311B1 (en) * 1999-05-05 2006-11-14 Institut Curie Means for detecting and treating pathologies linked to FGFR3
US6139535A (en) 1999-05-27 2000-10-31 Situs Corporation Method and apparatus for placement and activation of a medical device within a body cavity
DE60027458T2 (de) 1999-12-10 2007-07-05 Massachusetts Institute Of Technology, Cambridge Mikrochip-arzneistoffverabreichungssysteme und herstellungsverfahren
US6988983B2 (en) * 2000-04-14 2006-01-24 Solace Therapeutics, Inc. Implantable self-inflating attenuation device
US6682473B1 (en) * 2000-04-14 2004-01-27 Solace Therapeutics, Inc. Devices and methods for attenuation of pressure waves in the body
US6749553B2 (en) * 2000-05-18 2004-06-15 Theragenics Corporation Radiation delivery devices and methods for their manufacture
US6398718B1 (en) * 2000-06-15 2002-06-04 Innoventions, Inc. Intravesicular device
AU2002329842B2 (en) * 2001-08-29 2006-09-14 Umd, Inc. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
AU2002341959A1 (en) * 2001-10-04 2003-04-14 Case Western Reserve University Drug delivery devices and methods
US8685427B2 (en) 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
GB2385273B (en) * 2002-02-13 2004-05-26 Deborah Huang Drug delivery device
US6949125B2 (en) 2002-04-16 2005-09-27 Boston Scientific Scimed, Inc. Ureteral stent with end-effector and related methods
GB0211286D0 (en) 2002-05-16 2002-06-26 Nokia Corp Routing data packets through a wireless network
DE10247689A1 (de) * 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
CA2503193A1 (en) 2002-10-22 2004-05-06 The Biomerix Corporation Method and system for intravesicular delivery of therapeutic agents
EP1587450A2 (en) 2002-12-16 2005-10-26 The Regents Of The University Of Michigan Assembly and planar structure for use therein which is expandable into a 3-d structure such as a stent and device for making the planar structure
US20050228482A1 (en) * 2003-09-26 2005-10-13 William Herzog Stent covered by a layer having a layer opening
AU2005212165A1 (en) 2004-02-11 2005-08-25 Ethicon, Inc. System and method for urodynamic evaluation utilizing micro-electronic mechanical system
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
DK1933810T3 (da) * 2005-08-11 2013-01-28 Childrens Medical Center Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde
US20070255222A1 (en) 2006-03-27 2007-11-01 Changqing Li Catheter assembly including internal bolster
JP5191489B2 (ja) 2006-08-23 2013-05-08 エスヴイアイピー ２ エルエルシー 摂食行動を変更するデバイス及び方法
WO2008038281A2 (en) * 2006-09-28 2008-04-03 Medvision Inc. Examination device
US8128576B2 (en) 2006-12-07 2012-03-06 Ethicon, Inc. System and method for urodynamic evaluation utilizing micro electro-mechanical system technology
KR101538748B1 (ko) * 2007-12-11 2015-07-22 메사추세츠 인스티튜트 오브 테크놀로지 이식형 의약 투여 장치와 방광과 기타 신체 낭 또는 내강의 치료 방법
JP2011510750A (ja) * 2008-01-29 2011-04-07 クライマン、ギルバート・エイチ 薬物送達デバイス、キット及びそれらの方法
EA201170297A1 (ru) * 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
US20100048266A1 (en) 2008-08-19 2010-02-25 Samsung Electronics Co., Ltd. Antenna device
DK2445570T3 (da) * 2009-06-26 2013-02-25 Taris Biomedical Inc Implanterbare lægemiddelafgivelsesindretninger samt fremgangsmåder til deres fremstilling
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
PL3884988T3 (pl) * 2009-12-17 2025-09-08 Taris Biomedical Llc Urządzenie implantowalne z tolerancją wewnątrzpęcherzową

Also Published As

Publication number Publication date
JP2016022392A (ja) 2016-02-08
PT3884988T (pt) 2025-09-01
CA2784601C (en) 2016-06-14
US11890439B2 (en) 2024-02-06
JP6247270B2 (ja) 2017-12-13
JP6854210B2 (ja) 2021-04-07
ES2867399T3 (es) 2021-10-20
SI2512581T1 (sl) 2021-09-30
US20140221981A1 (en) 2014-08-07
US12576253B2 (en) 2026-03-17
RS67130B1 (sr) 2025-09-30
PL3884988T3 (pl) 2025-09-08
EP2512581A1 (en) 2012-10-24
AU2010339821A1 (en) 2012-07-05
LT2512581T (lt) 2021-03-25
US20210252262A1 (en) 2021-08-19
JP2013514837A (ja) 2013-05-02
PL2512581T3 (pl) 2021-11-02
PT2512581T (pt) 2021-04-27
SMT202100236T1 (it) 2021-05-07
EP2512581B1 (en) 2021-02-17
HUE073030T2 (hu) 2025-12-28
LT3884988T (lt) 2025-08-25
RS61980B1 (sr) 2021-07-30
ES3038403T3 (en) 2025-10-13
WO2011084712A1 (en) 2011-07-14
JP2017189688A (ja) 2017-10-19
SMT202500293T1 (it) 2025-09-12
HUE053888T2 (hu) 2021-07-28
US11065426B2 (en) 2021-07-20
US8679094B2 (en) 2014-03-25
DK2512581T3 (da) 2021-03-29
AU2010339821B2 (en) 2015-02-19
CY1124354T1 (el) 2022-07-22
HRP20250946T1 (hr) 2025-10-10
US20240198067A1 (en) 2024-06-20
FI3884988T3 (fi) 2025-08-08
US20110152839A1 (en) 2011-06-23
EP3884988A1 (en) 2021-09-29
CA2784601A1 (en) 2011-07-14
SI3884988T1 (sl) 2025-09-30
EP3884988B1 (en) 2025-06-18
DK3884988T3 (da) 2025-08-18

Similar Documents

Publication Publication Date Title
HRP20210329T1 (hr) Uređaj koji se može implantirati s intravezikalnom tolerancijom
JP2013514837A5 (https=)
HRP20202038T1 (hr) Pripravci namijenjeni kontinuiranoj primjeni inhibitora dopa-dekarboksilaze
JP2016532505A5 (https=)
JP2017500171A5 (https=)
RU2013138621A (ru) Имплантируемое устройство для контролируемого высвобождения лекарственного средства с низкой растворимостью
HRP20201421T1 (hr) Uređaji za davanje više jedinica lijeka
HRP20210356T1 (hr) Sistemi isporuke za protetski srčani zalistak
WO2010062688A3 (en) Dosage form for insertion into the mouth
HRP20251264T1 (hr) Sustavi za primjenu lijeka i metode za liječenje karcinoma mokraćnog mjehura gemcitabinom
WO2009058990A3 (en) Vascular closure device
WO2007021964A3 (en) Intravesical drug delivery device and method
EA201400172A1 (ru) Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
JP2010207585A5 (https=)
CL2007001417A1 (es) Inhalador para la administracion de una formulacion en polvo,desde un soporte con forma de cinta flexible que forma un bucle cerrado,con una pluralidad de alojamientos,con un dispositivo de transporte para el avance paso a paso del soporte que presenta dos cambios de sentido, y ruedas para avance accionadas por engranajes.
JP2012532772A5 (https=)
ES2531251T3 (es) Derivación de líquido cefalorraquídeo con administración de agente antioclusión prolongada
WO2008005176A3 (en) Electroactive polymer radiopaque marker
WO2008060360A3 (en) Implantable medical device with apertures for delivery of bioactive agents
PE20091574A1 (es) Sistema de administracion de drogas con efecto estabilizante
WO2008051881A3 (en) Bioabsorbable medical device with coating
BG108870A (en) Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
HRP20200879T1 (hr) Medicinski aplikator
MX349841B (es) Catéter con difusor distal.
CN203749989U (zh) 一种防返流胆道内外引流导管